STOCKHOLM – A trio of American scientists, one of them German-born, have won the Nobel Prize for Medicine for pioneering work on the body’s cell transport system, unlocking insights into diabetes, immune disorders and other diseases. James Rothman, Randy Schekman and Thomas Suedhof on Monday shared the prize for discovering how molecules vital to cellular functioning are shunted around in an internal freight system, tucked inside sacs called vesicles. They also helped resolve how the vesicles arrive on time and in the right place – a major riddle, given that this takes place in a microscopic environment humming with movement. If the package fails to show up at the right time, or goes to the wrong location, this can cause cellular malfunction. “Through their discoveries, Rothman, Schekman and Suedhof have revealed the exquisitely precise control system for the transport and delivery of cellular cargo,” the Nobel panel said. “Without this wonderfully precise organisation, the cell would lapse into chaos.” Suedhof, a professor of molecular and cellular physiology at Stanford University in California, was driving a car “in the middle of Spain” when reached by the Nobel Committee several hours after the announcement. “Are you serious? Oh, my God,” he said… Read full this story
- 2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers
- 2013 Nobel Prize Winners in Physiology or Medicine
- Top Physics Breakthroughs of the 13th Baktun
- Nobel prizes for individual scientists are an anachronism – Brian Keating
- Renowned Hoo-Ha Doctor Wins Nobel Prize For Medical Advancements Down There
- Gwen Ifill’s ‘The Breakthrough’
- The dangers of stem cell tourism
- Call to Action: Finding Heroes in Science and Engineering
- Absent-Minded Professor Says Cure For Cancer 'Around Here Somewhere'
- Dealing with some Pro-Life Arguments: Human Individuals
Cellular breakthrough earns trio Nobel for medicine have 276 words, post on vietnamnews.vn at October 8, 2013. This is cached page on Search. If you want remove this page, please contact us.